ClinicalTrials.gov
public full text
Public Domain
Study to Evaluate the Effects of AV-001 on HD-induced Brain Injury.
Cognitive decline is increasingly recognized among patients receiving maintenance hemodialysis (HD). This can include trouble remembering, slower thinking or mentally feeling foggy. This research is being done to determine if a new medication (AV-001) can protect the brain from injury caused by hemodialysis by strengthening blood vessels in the brain and reducing inflammation. If successful, this research could lead to better protection for the brains of people undergoing regular dialysis, potentially reducing the risk of cognitive decline and stroke.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Serum BDNF and cognitive risk in maintenance hemodialysis: a machine learning study.#1054317
- Effect of Raised CBF During CEA on Cognition in DM Patients#886915
- Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought#1096120
- The Effect of Intravenous Lactate on Brain Lactate Concentrations During Hypoglycemia#914886
- Effects of Diet on Brain Processing#883785
Record · ID 870212
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive